ArtVentive Medical Group, Inc. Announces Expanded Commercial Use and Post-Market Study of EOS(TM) Endoluminal ...

ArtVentive Medical Group, Inc. announced today additional excellent clinical results in the ongoing ArtVentive EOS™ Endoluminal Occlusion System, or ArtVentive EOS™, OCCLUDE I post-market surveillance ...



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1qnrrOZ

via IFTTT